On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013

Rev Esp Cardiol (Engl Ed). 2016 Jun;69(6):551-3. doi: 10.1016/j.rec.2016.03.009. Epub 2016 May 6.

[Article in English, Spanish]

Authors

Inmaculada Roldán¹, Francisco Marín²; Cardiovascular Thrombosis Group of the Spanish Society of Cardiology and the proposal development Committee; Spanish Society of Cardiology (SEC); Spanish Thrombosis and Hemostasis Society (SETH); Spanish Society of Neurology (SEN); Spanish Society of Emergency Medicine (SEMES); Spanish Society of Internal Medicine (SEMI); Spanish Society of Primary Care Physicians (SEMERGEN)

Affiliations

¹ Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain.
² Servicio de Cardiología, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain. Electronic address: fcomarino@hotmail.com.

PMID: 27162063
DOI: 10.1016/j.rec.2016.03.009

No abstract available

Publication types

Editorial

MeSH terms

Anticoagulants / therapeutic use*
Atrial Fibrillation / complications
Atrial Fibrillation / drug therapy*
Hemorrhage / chemically induced
Humans
Risk Assessment
Spain
Stroke / etiology
Stroke / prevention & control*
Warfarin / therapeutic use

Substances

Anticoagulants
Warfarin